BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29031365)

  • 21. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
    J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.
    Sokoya M; Chowdhury F; Kadakia S; Ducic Y
    Laryngoscope; 2018 Nov; 128(11):2573-2575. PubMed ID: 30194842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
    Abdalla AS; Sheybani ND; Khan SA
    PET Clin; 2022 Apr; 17(2):213-222. PubMed ID: 35256298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical
    Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
    Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
    Vahle AK; Hermann S; Schäfers M; Wildner M; Kerem A; Öztürk E; Jure-Kunkel M; Franklin C; Lang S; Brandau S
    Head Neck; 2016 Apr; 38(4):542-9. PubMed ID: 25482887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
    Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
    J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.
    Leung AS; Rath TJ; Hughes MA; Kim S; Branstetter BF
    Head Neck; 2016 Apr; 38 Suppl 1():E853-8. PubMed ID: 25917499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
    Cacicedo J; Navarro A; Del Hoyo O; Gomez-Iturriaga A; Alongi F; Medina JA; Elicin O; Skanjeti A; Giammarile F; Bilbao P; Casquero F; de Bari B; Dal Pra A
    Br J Radiol; 2016 Nov; 89(1067):20160217. PubMed ID: 27416996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
    Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
    Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of
    Ruhlmann V; Poeppel TD; Veit J; Nagarajah J; Umutlu L; Hoffmann TK; Bockisch A; Herrmann K; Sauerwein W
    BMC Cancer; 2017 Dec; 17(1):887. PubMed ID: 29273015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
    Mak D; Corry J; Lau E; Rischin D; Hicks RJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):487-99. PubMed ID: 22019706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond the
    Subramaniam RM; Marcus C
    AJR Am J Roentgenol; 2022 Feb; 218(2):384. PubMed ID: 34133207
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
    Matoba M; Tuji H; Shimode Y; Kondo T; Oota K; Tonami H
    Br J Radiol; 2017 Mar; 90(1071):20150404. PubMed ID: 28055245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.